Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#357 most reported symptom for this vaccine
Epistaxis has been reported 86 times in association with Hepatitis B (Engerix-B) vaccination in VAERS. This represents 0.1% of all 73,280 reports for this vaccine.
Among these reports, 19 mentioned death (22.09%) and 17 involved hospitalization (19.8%).
Epistaxis is the #357 most frequently reported symptom for Hepatitis B (Engerix-B) out of 2382 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 86 reports of Epistaxis after Hepatitis B (Engerix-B) vaccination may seem alarming, but context is critical.
The 22.09% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.